Category Specific RSS

News

Noxopharm receives FDA approval for testing of promising cancer treatment

Jennie Young was one of the first patients to receive Veyonda, Noxopharm’s (ASX: NOX) proprietary drug. Administered on compassionate grounds,…

5 years ago

Top of the class: Rhythm’s latest study results outperform the standard

Colorectal cancer is the third most commonly occurring cancer in men, and the second in women. Yet every year 130…

5 years ago

This company’s advanced 3D printing product could become industry standard

From dental devices to jet engines, 3D printing is quickly becoming mainstream. Its use is moving well beyond prototyping and…

5 years ago

Will this sporting tech IPO be a Hit?

Injury is inevitable in both elite and recreational sport. Most cuts, bruises, strains and tears can be remedied in a…

5 years ago

Small Caps Watch – Class Limited CEO and MD Andrew Russell

In this episode of Small Caps Watch, Emerald Financial's Bronte Moore is joined by the CEO and Managing Director of…

5 years ago

Can Medibio’s software redefine mental health diagnostics?

Mental illness will have an impact on 45% of Australians at some point in their lifetime. While the world is…

5 years ago

Mobecom adds Coles, Kmart, Bunnings and more as clients with Neat Ideas acquisition

A power balance is in the process of shifting in the retail world where brand loyalty is one of the…

5 years ago

Top ASX small caps fund eyes growth in this fintech with $3.5m on-market buying

As one of Australia’s most successful funds in the small cap space returning more than 100% in the past 12…

5 years ago

Ingenia are not taking a break, so you can

Australian’s are slowly pulling down their masks to embrace a new normal in the wake of the pandemic. Travel, at…

5 years ago

Lending giant secures stake in Novatti neobank with $18m funding commitment

Having built one of the most comprehensive networks of banking service partners over the past two years, digital payments company…

5 years ago